π Medicine Name:
Adenosine Injection 3 mg/mL
(Used as an antiarrhythmic agent)
π Description / Prescription:
Adenosine Injection is a rapid-acting intravenous medication used for the acute termination of paroxysmal supraventricular tachycardia (PSVT). Itβs a prescription-only drug, often used in emergency or hospital settings.
- Form: Sterile, clear, colorless solution
- Strength: 3 mg per mL
- Common pack sizes: 2 mL or 5 mL ampoules/vials
- Route: IV bolus injection only
π©Ί Indications:
- Paroxysmal supraventricular tachycardia (PSVT)
- Diagnostic aid in wide complex tachycardia or narrow complex tachycardia
- May help identify or unmask underlying atrial activity (e.g., flutter, fibrillation)
π¬ Nature / Mechanism of Action:
Adenosine is a naturally occurring nucleoside that works by:
- Slowing conduction through the AV node
- Interrupting reentrant circuits in AV nodal tissue
- Temporarily blocking AV node conduction, which allows restoration of sinus rhythm
π Onset: 10β30 seconds
β³ Half-life: <10 seconds (extremely short)
𧬠Acts on A1 adenosine receptors in the heart
β Advantages / Therapeutic Benefits:
- β Rapid onset and short durationβideal for emergency use
- β Can restore normal rhythm within seconds
- β Reduces need for electrical cardioversion
- β Useful as a diagnostic tool in complex arrhythmias
- β Generally well tolerated due to short action
π¦ Packaging:
- Supplied as 3 mg/mL in:
- 2 mL ampoules (6 mg total)
- 5 mL ampoules (15 mg total)
- Single-dose ampoules or vials
- Labeled for IV use only
π‘οΈ Storage:
- Store at 15β25Β°C (59β77Β°F)
- Protect from light and freezing
- Use immediately after opening
- Do not refrigerate
β οΈ Precautions / Contraindications:
Contraindications:
- Second or third-degree AV block (without pacemaker)
- Sick sinus syndrome (without pacemaker)
- Asthma or severe bronchospasm
- Known hypersensitivity to adenosine
Caution in:
- Heart transplant recipients (may require lower dose)
- Seizure disorders
- Concurrent use of dipyridamole (potentiates adenosine)
- Theophylline or caffeine (reduce adenosine effect)
π Administration Notes (For Healthcare Providers):
- Administer as a rapid IV bolus (over 1β2 seconds)
- Follow immediately with a flush of normal saline (β₯20 mL)
- Preferably via central line or large peripheral vein near the heart
- Patient should be supine, and ECG monitored continuously during administration
- Initial dose: 6 mg β if no response, 12 mg after 1β2 minutes β repeat 12 mg if needed
- Max dose: 30 mg total
π©ββοΈ Patient Advice / What to Expect:
- Patients may feel brief flushing, chest pressure, breathlessness, or dizziness for a few seconds
- These effects are very short-lived (less than 1 minute)
- Should be reassured that symptoms are expected and resolve quickly
- Not for regular useβused only in acute hospital setting

